Assistant Professor, Director of chimeric antigen receptor T-cell (CAR-T cell) for multiple myeloma
Dr. Kocoglu focuses on the treatment of multiple myeloma including high-risk myeloma. He specializes in cellular therapies of myeloma including stem cell transplantation as well as CART cell and bispecific antibody (i.e. biologic) therapies of myeloma, AL amyloidosis and POEMS syndrome.
years treating myeloma: 17
Number of Myeloma Patients Treated Annually: 650
Details & contact info
Cider Alley Ridgleys Delight
Baltimore, MD, United States, 21201
Send a message to Mehmet Kocoglu, MD